Eli Lilly is currently leading the market for GLP-1 drugs, taking the pole position from Novo Nordisk. Novo Nordisk just got approval for a GLP-1 pill, which could again upend the dynamics for weight ...

Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...

The deal requires the pharmaceutical companies to match what they charge in other developed countries for newly launched medications, including in commercial and cash-pay markets, as well as Medicare ...

President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer ...

Drugmakers to cut prices on most drugs sold to the Medicaid program U.S. patients pay the most for prescription medicines Dec 19 (Reuters) - U.S. President Donald Trump and nine major pharmaceutical ...

The White House announced Friday that nine additional pharmaceutical companies have agreed to follow President Trump’s “most favored nation” (MFN) drug pricing policy, with some of the companies ...

President Trump on Friday announced new agreements with nine pharmaceutical manufacturers aimed at reducing certain prescription drug prices. "Starting next year, American drug prices will come down ...

Nine pharmaceutical companies including Bristol-Myers Squibb, GSK and Merck agreed to lower the prices that certain federal government programs and patients pay, in a new round of industry pacts with ...

President Donald Trump announced Friday his administration has reached new agreements with some of the world’s largest drug manufacturers aimed at lowering prescription drug costs for Americans.